Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.

Routine infant immunization with 10-valent pneumococcal conjugate vaccine (PCV-10) began in Brazil in 2010. The impact of the PCV-10 on rates of invasive pneumococcal disease (IPD) at the population level was not yet evaluated. Serotype-specific IPD changes after PCV-10 introduction is still to be determined. Data from national surveillance system for notifiable diseases (SINAN) and national reference laboratory for S. pneumoniae in Brazil (IAL) were linked to enhance case ascertainment of IPD. An interrupted time-series analysis was conducted to predict trends in the postvaccination IPD rates in the absence of PCV-10 vaccination, taking into consideration seasonality and secular trends. PCVs serotype-specific distribution were assessed before (2008-2009) and after (2011-2013) the introduction of PCV-10 in the immunization program. A total of 9,827 IPD cases were identified from 2008-2013 when combining SINAN and IAL databases. Overall, PCV-10 types decreased by 41.3% after PCV-10 vaccination period, mostly in children aged 2-23 months, while additional PCV-13 serotypes increased by 62.8% mainly in children under 5-year of age. For children aged 2-23 months, targeted by the immunization program, we observed a 44.2% (95%CI, 15.8-72.5%) reduction in IPD rates. In contrast, significant increase in IPD rates were observed for adults aged 18-39 y (18.9%, 95%CI 1.1-36.7%), 40-64 y (52.5%, 95%CI 24.8-80.3%), and elderly ≥ 65 y (79.3%, 95%CI 62.1-96.5%). This is the first report of a time-series analysis for PCV impact in IPD conducted at national level data in a developing country. We were able to show significant impact of PCV-10 on IPD for age groups targeted by vaccination in Brazil, 3 y after its introduction. No impact on other age groups was demonstrated.

Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED.

BACKGROUND: Several primary immune deficiency disorders are associated with autoimmunity and malignancy, suggesting a state of immune dysregulation. The concept of immune dysregulation as a direct cause of autoimmunity in primary immune deficiency disorders (PIDDs) has been strengthened by the recent discovery of distinct clinical entities linked to single-gene defects resulting in multiple autoimmune phenomena including immune dysregulation, polyendocrinopathy, enteropathy and X-linked (IPEX) syndrome, and autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED) syndrome. CONCLUSION: Reviewing recent advances in our understanding of the small subgroup of PIDD patients with defined causes for autoimmunity may lead to the development of more effective treatment strategies for idiopathic human autoimmune diseases.

Autosomal recessive interleukin-1 receptor-associated kinase 4 deficiency in fourth-degree relatives.

We report a kindred with autosomal recessive interleukin-1 receptor-associated kinase 4 (IRAK-4) deficiency in 3 fourth-degree relatives. A diagnosis of IRAK-4 deficiency should be considered in families with invasive bacterial disease, even if the individuals affected are only distantly related, which falsely suggests multigenic or dominant inheritance with low penetrance.

Mycobacterium bovis dissemination (BCG strain) among immunodeficient Brazilian infants.

This study reports Mycobacterium bovis (BCG strain) dissemination in four primary immunodeficient (PID) patients. Their diagnoses were: chemotaxis defect, cellular immunodeficiency, combined immunodeficiency and chronic granulomatous disease (CGD). Patients were vaccinated with BCG (Moreau strain) between 17 days and 4 months of age. Identification of the BCG strain was performed in many sites, such as bone marrow, ganglionic mass, cerebrospinal fluid and in the site of vaccination. The first therapeutic schedule included rifampicin, isoniazid and ethambutol; no uniform treatment could be used for these patients. Therapy was adjusted as required on the basis of BCG sensitivity results. This study shows that PID patients are susceptible to BCG dissemination and demonstrates the importance of an early diagnosis for their prognosis.

Inmunodeficiencias / Immunodeficiencies

Las inmunodeficiencias son un grupo heterogéneo de enfermedades que se clasifican en primarias o secundarias. Las primarias corresponden a un pequeño grupo de enfermedades bien caracterizadas y que son habitualmente congénitas; las secundarias, son bastante más frecuentes y acompañan a la gran mayoría de las enfermedades crónicas en adultos. En el presente resumen se muestra en forma general la clasificación de estas enfermedades, sus características clínicas y de laboratorio y lo más importante, se da una pauta guía para enfrentar este tipo de problemas partiendo desde su identificaciíon precoz y algunas medidas terapéuticas de apoyo

Increment of enterobacterial common antigens in organ extracts from immunosuppressed mice.

This article describes the enterobacterial common antigen (ECA) content in the liver and spleen extracts from immunosuppressed two months old CFW mice which received a single dose (400 mg/kg body weight) of cyclophosphamide (CY). A complement fixation inhibition assay was used to measure the tissular concentration of ECA. The results showed that liver and spleen ethanol-soluble extracts from immunosuppressed mice had a greater quantity of ECA than those obtained from healthy mice (p < 0.001). Previous works have proven that ECA is a hapten shared by almost all Gram-negative bacteria, and CY is an alkylating agent useful to induce bacterial translocation. Therefore, the increments observed in tissular ECA concentration may indicate the extension of the enterobacterial dissemination from intestine to abdominal organs in CY-treated immunosuppressed mice.